CVS Health (NYSE:CVS) Posts Quarterly Earnings Results, Beats Expectations By $0.30 EPS

CVS Health (NYSE:CVS) released its earnings results on Wednesday. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30, Zacks reports. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health updated its FY 2025 guidance to 5.750-6.000 EPS.

CVS Health Stock Up 13.5 %

Shares of CVS Health stock traded up $7.43 during trading on Wednesday, hitting $62.43. 15,775,014 shares of the stock were exchanged, compared to its average volume of 12,462,962. The stock has a market cap of $78.57 billion, a price-to-earnings ratio of 15.88, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The firm’s 50-day moving average price is $50.61 and its 200 day moving average price is $55.92. CVS Health has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.26%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Royal Bank of Canada cut their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Tuesday, December 3rd. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Finally, Piper Sandler dropped their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $67.78.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.